Timothy Edwin Kelly - 14 Nov 2022 Form 4 Insider Report for Praxis Precision Medicines, Inc. (PRAX)

Role
Chief Financial Officer
Signature
/s/ Alex Nemiroff, as Attorney-in-Fact
Issuer symbol
PRAX
Transactions as of
14 Nov 2022
Net transactions value
+$9.06
Form type
4
Filing time
21 Nov 2022, 05:04:54 UTC
Previous filing
24 Jun 2022
Next filing
09 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRAX Common Stock Award $9.06 +5 +0.01% $1.81 40,495 14 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).